HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Q1 Sales Round-Up: Karo Pharma, Boiron And Ipsen

Executive Summary

Consumer health first-quarter results round-up featuring Karo Pharma, Boiron and Ipsen.

You may also be interested in...

Boiron Posts Big Sales Gain As It Benefits From Easy Comp

French homeopathy specialist Boiron reported sales up by 60% in Q1 as the business returned to growth following the end of COVID-19 social restrictions.

Ipsen Weighing Consumer Business Sale After Challenging 2020

Ipsen CEO David Loew has kicked off a strategic review of the company's "non core" Consumer Healthcare business, which has endured a particularly tough year thanks to the COVID-19 pandemic.

France's Boiron Diversifies Into Probiotics To Arrest Sales Decline

Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts